Wed, 22 May 2019

Philadelphia [USA], April 17 (ANI): The first human trials of the controversial gene editing technology called CRISPR, has officially started in the US.

Researchers at the University of Pennsylvania, are conducting a powerful experiment on cancer patients. As NPR reports, one patient had multiple myeloma and another one had sarcoma. Both the patients had relapsed after undergoing the standard treatment.

CRISPR is a technique in which modifications are made at the DNA level, with the potential to cure many diseases. A Chinese scientist, He Jiankui, used the technique to edit genes in human embryos that are now the world's first CRISPR twins. (ANI)

Sign up for China News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!